
Researchers developed and validated an AI model that simultaneously detects multiple genetic markers in colorectal cancer tissue slides.
Key Details
- 1Study led by EKFZ for Digital Health at TU Dresden analyzed nearly 2,000 digitized pathology slides across seven independent cohorts in Europe and the US.
- 2The AI 'multi-target transformer' model predicts a wide range of genetic alterations, including microsatellite instability and BRAF/RNF43 mutations, from routine histological sections.
- 3Model performance matched or exceeded single-target models for key biomarkers and revealed the ability to identify shared morphological patterns tied to multiple mutations.
- 4Findings published in The Lancet Digital Health, with plans to extend methods to other cancers.
- 5Collaboration involved multiple academic centers, highlighting interdisciplinary and international partnership.
Why It Matters

Source
EurekAlert
Related News

MD Anderson Unveils New AI Genomics Insights and Therapeutic Advances
MD Anderson reports breakthroughs in cancer therapeutics and provides critical insights into AI models for genomic analysis.

UCLA Researchers Present AI, Blood Biomarker Advances at SABCS 2025
UCLA Health researchers unveil major advances in breast cancer AI pathology, liquid biopsy, and biomarker strategies at the 2025 SABCS.

SH17 Dataset Boosts AI Detection of PPE for Worker Safety
University of Windsor researchers released SH17, a 8,099-image open dataset for AI-driven detection of personal protective equipment (PPE) in manufacturing settings.